Skip to main content

Table 2 Correlation between the FAR and clinicopathological variables in STS patients

From: Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma

Variables FAR p-value
< 0.0726, n (%) ≥0.0726, n (%)
Gender
 Male 100 (56.8) 74 (55.2) 0.779
 Female 76 (43.2) 60 (44.8)
Age (years)
 < 50 136 (77.3) 72 (53.7) <0.001
 ≥ 50 40 (22.7) 62 (46.3)
Tumor size (cm) <0.001
 < 5 98 (55.7) 45 (33.6)
 ≥ 5 78 (44.3) 89 (66.4)
Tumor depth <0.001
 Superficial 92 (52.3) 35 (26.1)
 Deep 84 (47.7) 99 (73.9)
Tumor grade    0.002
 G1 60 (34.1) 22 (16.4)
 G2 64 (36.4) 55 (41.0)
 G3 35 (19.9) 45 (3.6)
 Missing 17 (9.7) 12 (9.0)
AJCC stage 0.001
 IA + IB 61 (34.7) 22 (16.4)
 IIA + IIB 75 (42.6) 66 (49.3)
 III + IV 25 (14.2) 37 (27.6)
 Unknown 15 (8.5) 9 (6.7)
NLR
 < 2.51 148 (84.1) 66 (49.3) <0.001
 ≥ 2.51 28 (15.9) 68 (50.7)
PLR <0.001
 < 191.1 165 (93.8) 100 (74.6)
 ≥ 191.1 11 (6.3) 34 (25.4)
Recurrence 0.001
 YES 50 (28.4) 62 (46.3)
 NO 126 (71.6) 72 (53.7)
Metastasis 0.005
 YES 25 (14.2) 36 (26.9)
 NO 151 (85.8) 98 (73.1)